clinical trial · NCT06285214
Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome
Interstitial Cystitis/Bladder Pain SyndromeV117957Placebo
brief summary
The purpose of this study is to evaluate the safety, tolerability and efficacy of V117957 in subjects with interstitial cystitis/bladder pain syndrome, compared to placebo.
started
May 26, 2022
primary completion
Jan 28, 2025
completion
Jan 28, 2025
last updated
Mar 9, 2026
official title
Multicenter, Randomized, Double-blind Placebo-controlled, Crossover Study to Investigate Effects of V117957 in Female Subjects With Interstitial Cystitis/Bladder Pain Syndrome
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol